Race against frostbite: can a heart drug stop amputations?
NCT ID NCT07424378
Summary
This study is testing whether adding an intravenous drug called epoprostenol to the current standard treatment for severe frostbite can help save fingers and toes from amputation. The drug works by opening blood vessels and preventing clots to improve blood flow to the frozen tissue. About 66 adults with serious frostbite will receive either the drug or a placebo (saltwater) infusion for 5 days, in addition to all other standard treatments, to see which group has better outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FROSTBITE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Colorado, Denver
Aurora, Colorado, 80045, United States
-
University of Colorado, Denver
Aurora, Colorado, 80045, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.